PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2134034
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2134034
Sleep Apnea Devices market size was valued at US$ 7,110.8 Million in 2025, expanding at a CAGR of 10.6% from 2026 to 2033.
Sleep apnea is known to be a medical condition, which is considered a treatable and quite serious type of sleep disorder that causes disturbances in the breathing cycle of an individual. In case of sleep apnea, the patient will have difficulties with his breathing process while sleeping, since adequate oxygen supply to his brain and organs cannot be guaranteed. The patients with such medical conditions as diabetes, heart problems, and hypertension, as well as elderly patients, are usually the ones most affected by sleep apnea.
Among various types of sleep apnea globally diagnosed in people, OSA or obstructive sleep apnea is the most common type. Diagnosis and application of treatment devices become crucial for preventing further health problems and disorders caused by this sleep apnea type. This means that the need to use home sleep apnea test devices emerges, because they can provide enough time for treatment and prevention of any systemic diseases in the future. Thus, CPAP therapy becomes the gold standard for treatment of this sleep apnea type.
Sleep Apnea Devices Market- Market Dynamics
Growing Adoption of Advanced Devices for Sleep Apnea Management to Fuel Market Expansion
Increasing adoption of advanced devices for sleep apnea management is expected to drive demand for new therapeutic and diagnostic devices, because the advanced technology does not require complex manual adjustments, regular clinical visits, and surgical procedures for its appropriate treatment. For instance, in October 2025, according to the study published in NIH Gov, research involving mandibular advancement devices (MADs) used for the treatment of OSA shows that there are 2,610 papers on this device, out of which 91% are from the past two decades. Out of them, 62% of the papers were published in the last decade, and all of them received 22.96 citations. The total number of citations made by these papers was 59,930, and it averaged 22.96 citations per paper. It should be noted that the research shows that the searches made on Google for "oral appliances for sleep apnea" grew by more than 200%, proving the increasing popularity of MADs among people unable to tolerate CPAP therapy. These findings highlight the rising preference and research momentum behind oral appliances in sleep therapy.
The Global Sleep Apnea Devices market is segmented on the basis of Product Type, Age Group, Gender, End User, and Region.
Under product type, therapeutic devices hold the major place in the Sleep Apnea Devices market due to the increased use of therapeutic treatment devices such as the continuous positive airway pressure system, oral appliance, and airway clearance device with an efficient delivery of constant airflow in order to maintain open airways during sleep. In October 2025, ResMed introduced its new AirTouch(TM) F30i Comfort full-face mask in Australia; it is made up of a soft fabric cushion and a fabric-covered frame in order to provide comfort to the patients undergoing continuous positive airway pressure therapy for the treatment of obstructive sleep apnea. These ongoing advancements in therapeutic devices continue to strengthen their leading role in sleep apnea care.
Sleep Apnea Devices Market- Geographical Insights
North America accounts for a significant portion of the market because of the increasing prevalence of respiratory diseases and obesity along with the high level of awareness of obstructive sleep apnea. For instance, in July 2026, according to the National Council on Aging (Org), there are 83.7 million (32.4%) U.S. adults ages 20 years and above who suffer from sleep apnea (OSA), which implies an estimate of how many people have OSA within the United States. But 80% of sleep apnea cases go undiagnosed, and one of the factors that contribute to this problem is the unawareness on the part of healthcare professionals as well as patients. This highlights the importance of raising awareness and recognizing obstructive sleep apnea within the United States. Hence, this huge diagnostic gap is crucial for expanding the sleep apnea market in the region.
Australia Sleep Apnea Devices market - Country Insights
Australia is one of the many emerging countries where the number of sleep apnea cases has increased significantly. For instance, in September 2025, according to the Australian Nursing & Midwifery Journal (Org), because of the rising temperature levels, there was a 45% chance that a patient would have OSA, and by the year 2100, the impact of climate change on this disease in Australia will be twice as high. In this case, the research done involved more than 116,000 patients from all around the world, and the rise in the number of OSA patients was caused by increased temperatures due to global warming. As a result of this issue, there has been a loss of more than 800,000 years of healthy lives in 29 different countries. According to predictions, the economic cost of poor sleep, particularly OSA, in Australia will be about $66 billion annually. These findings underscore the urgent need for targeted healthcare strategies to mitigate climate-driven sleep disorders.
The Sleep Apnea Devices market features established players such as ResMed, Philips Respironics, Fisher & Paykel Healthcare, Lowenstein Medical, and Invacare, which will be continuing to work on the provision of the full-fledged product portfolio along with the technologies that will help in driving the growth of the sleep apnea devices market. The efforts made by the companies towards making developments in sleep therapy solutions, along with connectivity technology, will further assist the companies in creating a competitive position in the coming years. In May 2026, ResMed entered into a strategic collaboration with OURA to develop a smart ring biometric solution for clinical sleep care pathways for early screening and diagnosis of obstructive sleep apnea. These strategic initiatives collectively drive market expansion by advancing diagnostic accuracy and patient compliance.
In February 2026, Invacare made changes to its global organization by merging the Europe and Asia Pacific segments with Direct Healthcare Group to create DHCare, staying concentrated on homecare equipment, as well as retaining the company's main respiratory support devices manufacturing segment.
In August 2025, Fisher & Paykel Healthcare launched a campaign titled "Powered by Curiosity" for full face masks in the US, which was part of the company's marketing strategy for their interface products for obstructive sleep apnea that includes Evora Full Face, Vitera, and Simplus masks.